Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Major Shareholder J.H. Whitney Equity Partners V Sells 5,580 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the completion of the transaction, the insider now directly owns 1,451,598 shares of the company's stock, valued at $8,172,496.74. This represents a 0.38 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total transaction of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64.

Aveanna Healthcare Price Performance

Shares of AVAH traded down $0.16 during midday trading on Tuesday, reaching $4.80. The stock had a trading volume of 317,028 shares, compared to its average volume of 250,359. The company has a market capitalization of $936.45 million, a P/E ratio of -14.12 and a beta of 1.99. The firm's 50 day moving average price is $4.78 and its 200-day moving average price is $4.95. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.11 and a 52 week high of $6.19.

Remove Ads

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the business. KLP Kapitalforvaltning AS bought a new position in shares of Aveanna Healthcare during the 4th quarter valued at about $35,000. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare during the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC boosted its holdings in Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd grew its position in Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after buying an additional 9,000 shares during the last quarter. Finally, Sagespring Wealth Partners LLC bought a new position in shares of Aveanna Healthcare in the fourth quarter valued at $57,000. 87.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Truist Financial decreased their price objective on shares of Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating for the company in a report on Monday, January 6th. UBS Group lifted their price target on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the company a "sell" rating in a report on Friday, March 14th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.